Under the leadership of Dr. Copeland, chief of cardiovascular and thoracic surgery and co-director of the University of Arizona Sarver Heart Center, University Medical Center in 1985 marked the first use in the world of a total artificial heart, the "Phoenix Heart," as a "bridge to transplant."
Dr. Copeland went on to help develop the CardioWest Total Artificial Heart, which has been used as a bridge to transplant in more than 175 patients worldwide since its first use in 1983. The device currently is undergoing approval from the Food and Drug Administration.
The CardioWest heart is the direct descendant of the Jarvik heart, which was developed at the University of Utah. It was implanted in Barney Clark in 1982 as a permanent replacement for his own heart. He survived on the device for 112 days.
Other highlights in Dr. Copeland's use of heart devices:
Dr. Copeland received the award, presented by the Medforte Research Foundation in conjunction with the Utah Artificial Heart Institute, at the annual conference of the American Society for Artificial Internal Organs, held in New York earlier this month.